| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.4B | $1.4B | $0.7B | $0.1B | $0.4B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | $0.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.0B | $0.1B | $0.0B | $0.0B | $-0.1B | $-0.3B | $0.2B | $0.1B |
| Net Income | $-0.1B | $-0.0B | $-0.1B | $-0.1B | $-0.2B | $-0.2B | $0.0B | $-0.1B |
| EPS (Basic) | $-0.90 | $-0.39 | $-0.93 | $-0.95 | $-1.80 | $-1.39 | $0.08 | $-1.16 |
| EPS (Diluted) | $-0.90 | $-0.39 | $-0.93 | $-0.95 | $-1.80 | $-1.39 | $0.08 | $-1.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.3B | $5.7B | $5.8B | $6.1B | $6.3B | $6.1B | $6.5B | $7.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | $2.8B | $2.9B | $3.0B | $3.0B | $3.1B | $2.8B | $2.9B | $3.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.5B | $2.7B | $2.8B | $3.0B | $3.2B | $3.3B | $3.6B | $3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.3B | $0.2B | $0.3B | $0.1B | $-0.2B | $0.4B | $0.1B |
| Investing Cash Flow | $0.0B | $-0.1B | $0.1B | $-0.1B | $-0.1B | $0.3B | $0.3B | $-1.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.2B | $-0.2B | $-0.2B | $-0.0B | $0.0B | $-0.7B | $1.7B |